Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324921 · ClinicalTrials.gov registry record · Phase 2
Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics
A Phase 2 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 2
- Development phase
- 37
- Enrollment target
NCT01324921 is a Phase 2 study that has completed, run by Abbott Nutrition. The registered enrollment target is 37 participants.
The verdict
NCT01324921, a Phase 2 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 37 participants
- Enrollment target
Study Summary
To compare the postprandial glycemic and insulinemic response of subjects with type 2 diabetes consuming a typical breakfast meal or no breakfast to 10004RF via a meal tolerance test (MTT).
Interventions
- OTHER No breakfast/beverage only
- OTHER Breakfast
- OTHER 10004RF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2010-08 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01324921
The ClinicalTrials.gov registry entry for NCT01324921 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which No breakfast/beverage only is the first listed.
NCT01324921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01324921 about?
NCT01324921 is a clinical study titled "Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics". To compare the postprandial glycemic and insulinemic response of subjects with type 2 diabetes consuming a typical breakfast meal or no breakfast to 10004RF via a meal tolerance test (MTT).
What is the current status of trial NCT01324921?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 37 participants. The study started on 2010-08. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01324921?
The interventions under investigation include: No breakfast/beverage only (OTHER), Breakfast (OTHER), 10004RF (OTHER).
Who is sponsoring clinical trial NCT01324921?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.